European Archives - Page 656 of 1125 - European Medical Journal

EAACI Interview: Prof Antonella Muraro

Prof Antonella Muraro | University of Padua and University Hospital of Padua, Padua, ItalyChair of the EAACI Guidelines CommitteeEAACI Past-President (2015–2017)…

A Review of Primary Immune Deficiency Disorders

This scenario-based review of primary immunodeficiency diseases (PIDD) discusses the differential diagnosis, usual presentations, work-up, and treatment…

A Qualitative Enquiry into the Lived Experiences of Adults with Atopic Dermatitis

Background: atopic dermatitis (AD) has been related to poorer health-related quality of life (HRQoL) in adults and there is lack of qualitative research…

Dynamic and Behaviour of Plane Tree Pollen and Its Relationship with Pla a 1 Aeroallergen Concentration in Évora, Portugal

Platanus pollen is an important cause of allergy in many cities of western Europe, where this pollen is produced by the plane tree, Platanus orientalis L. var. acerifolia Dyand (Aiton)…

Post Fever Uveoretinal Manifestations in an Immunocompetent Individual

Post fever uveoretinal sequelae (PFURS) are the various uveoretinal manifestations seen after a systemic febrile illness in an immunocompetent individual…

Personalised Immunoinflammatory Phenotypes of Children With Viral Bronchiolitis

In early life, the immune and respiratory system are functionally immature, presenting a window of susceptibility in which a subset of infants…

EMJ Podcast: 2020 Vision in IBD

This episode provides an overview of the symposium ‘20 20 Vision in IBD’ from ECCO. Listen now for more details

EMJ Podcast: Managing AF Patients with ACS and/or Undergoing PCI

In this episode Jonathan Sackier chats to Dr Amit Vora from Duke University about the results of the AUGUSTUS trial.

Credit Card-Sized Tool to Grow Cancer Cells Outside of the Human Body

INVASION and metastasis of tumour cells poses a significant challenge in cancer treatment; in the face of growing concerns, a team at

Is Immunotherapy Safe for COVID-19 Patients?

COMORBID COVID-19 and cancer is complicated by immunotherapy treatment, which activates an immune system response that may already be overactive